Egil Fosslien

866 citations
18 papers · 720 indexed · h-index 10
Topics
Advanced Proteomics Techniques and Applications (6 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)Inflammatory mediators and NSAID effects (3 papers)
Partner nations
United States

In The Last Decade

Egil Fosslien

18 papers receiving 689 citations

Peers

Egil Fosslien
Comparison fields: 5 of 95
  • Pharmacology 319
  • Molecular Biology 216
  • Genetics 161
  • Cancer Research 122
  • Oncology 91
Replace Daniel Pelot with:
Daniel Pelot United States
Keng-Mean Lin United States
Ming‐Derg Lai Taiwan
Hsin-Hsiung Tai United States
Junli Zhang China
N S Paranka United States
D M Nikoloff United States
Eun Ju Kim South Korea
Xu Zheng China
Hiroyasu Imanishi Japan
Egil Fosslien relative to Daniel Pelot United States Daniel Pelot's profile →
Citations per field
00.5×1.7×
Daniel Pelot · 1×
Citations per year

Countries citing papers authored by Egil Fosslien

Since Specialization
Citations

This map shows the geographic impact of Egil Fosslien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egil Fosslien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egil Fosslien more than expected).

Fields of papers citing papers by Egil Fosslien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egil Fosslien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egil Fosslien. The network helps show where Egil Fosslien may publish in the future.

Co-authorship network of co-authors of Egil Fosslien

This figure shows the co-authorship network connecting the top 25 collaborators of Egil Fosslien. A scholar is included among the top collaborators of Egil Fosslien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egil Fosslien. Egil Fosslien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 4
3 12
4
Cancer morphogenesis: role of mitochondrial failure.
30
5
Cardiovascular complications of non-steroidal anti-inflammatory drugs.
86
6
Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.
55
7
Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.
168
8 258
9 21
10 28
11 5
12 8
13 3
14 12
15 15
16 4
17 4
18 6

About Egil Fosslien

Egil Fosslien is a scholar working on Spectroscopy, Clinical Biochemistry and Physiology, having authored 18 papers that have together received 720 indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (6 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Pharmacology (319 citations), Biochemistry (85 citations) and Cancer Research (122 citations). Egil Fosslien has collaborated with scholars based in United States. Frequent co-authors include George Gee Jackson, V. T. Lolans, George L. Daikos, Abel L. Robertson, Rameshwar Prasad, F Musil, Sheldon Feldman and H. M. Yamashiroya. Their work appears in journals such as The American Journal of Medicine, Journal of Chromatography A and Electrophoresis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026